Article

Article

Washington Man Facing Prison After Foraging for Wild Mushrooms

Paul Lee Corbett is facing a potential prison sentence of five years for possession of psilocybin mushrooms.

Article

The latest piece on psychedelic science in the New York Times is dead wrong

First, the entire premise—that Schedule I status is the primary obstacle to research—is flat-out wrong.

Article

I wanted ayahuasca to teach me how to love the world despite its violence, destruction, and greed

After getting off my long dependence on anti-depressants, I found myself feeling open to natural therapies.

Article

Psychedelic medicines can help heal the trauma of mass incarceration

Psychedelic therapy has the potential to ignite a paradigm shift within our culture by enabling us to reframe complex social problems as manifestations of trauma.

Article

4 Reasons Why The U.S. Needs to Decriminalize Drugs, And Why We’re Closer Than You Think

There’s an emerging public, political, and scientific consensus that otherwise-law-abiding people should not be arrested simply for using or possessing a drug.

Article

Psychedelic Harm Reduction in the Czech Republic

The Czech Psychedelic Society is creating the Czech version of Zendo Project and KosmiCare.

Article

The Psychedelic Renaissance owes its life to an open internet

We must remember how in less than two decades, an open internet enabled us to bridge some deep cultural divides, dismantle three-quarters of a century worth of drug propaganda, crowdsource massive databases of drug information, and crowdfund millions of dollars for FDA-approved research on…

Article

A persuasive case for the decriminalization of drugs, Pt. 1

If neither the state nor defenders of our continued drug policies can provide a rational justification for the continued practice of incarcerating drug users, then the use of punishment by the state against drug users is morally unjustified.

Article

I was an MDMA manufacturer in the ’80s. Then fled the country as a fugitive for 20 years. | Part 3

This is part 3 of a 3-part series that follows the story of scientist, chemist, and fugitive, Robert Widdowson. During the 1980’s Widdowson manufactured the MDMA analogue MDHA in Santa Fe, New Mexico until he was arrested and charged under the Federal Analogues Act.

Article

I was an MDMA manufacturer in the ’80s. Then fled the country as a fugitive for 20 years. | Part 2

This is part 2 of a 3-part series that follows the story of scientist, chemist, and fugitive, Robert Widdowson. During the 1980’s Widdowson manufactured the MDMA analogue MDHA in Santa Fe, New Mexico until he was arrested and charged under the Federal Analogues Act.

Article

I was an MDMA manufacturer in the ’80s. Then fled the country as a fugitive for 20 years. | Part 1

This is part 1 of a 3-part series that follows the story of scientist, chemist, and fugitive, Robert Widdowson. During the 1980’s Widdowson manufactured the MDMA analogue MDHA in Santa Fe, New Mexico until he was arrested and charged under the Federal Analogues Act. This is his story.

Article

We need ecstasy and opioids in place of Prozac and Xanax

Instead of worrying so much about addiction, which tends to correct itself when life becomes tolerable, maybe we should worry more about the sources of emotional suffering.